ECONOMIC ASSESSMENT OF MAGNESIUM DEFICIENCY CORRECTION FOR BASIC THERAPY EFFICACY OF UNCONTROLLED ASTHMA IN CHILDREN

Abstract

Concomitant correction of magnesium deficiency in children with uncontrolled asthma can improve the efficiency of basic therapy for achieving asthma control and possesses pharmacoeconomic benefits, reducing the cost of achieving control and cost per symptom-free day after 12 and 24 weeks of therapy. The article “Economic Assessment of Magnesium Deficiency Correction for Basic Therapy Efficacy of Uncontrolled Asthma in Children”: expression of concern

Keywords

• children
• magnesium deficiency
• asthma
• pharmacoeconomic studies
• analysis of the «cost / benefit»